These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2980307)

  • 1. Synthesis, analysis and toxicity of some compounds which may be formed during the synthesis of iopentol.
    Berg A; Fagervoll R; Aulie Michelet A; Dugstad H
    Acta Radiol Suppl; 1987; 370():27-31. PubMed ID: 2980307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, isomerism and characterization of iopentol.
    Berg A; Fagervoll R
    Acta Radiol Suppl; 1987; 370():13-21. PubMed ID: 2980305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute toxicity of iopentol in rodents.
    Michelet AA; Salvesen S; Renaa T
    Acta Radiol Suppl; 1987; 370():41-4. PubMed ID: 2980310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of the toxicologic profile of iopentol.
    Heywood R; Mayfield R; Allan JA; Michelet AA
    Acta Radiol Suppl; 1987; 370():45-8. PubMed ID: 2980311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and stability of iopentol.
    Skinnemoen K; Fagervoll R; Aanstad L; Jacobsen T
    Acta Radiol Suppl; 1987; 370():37-40. PubMed ID: 2980309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray contrast agents. I. Synthesis of some derivatives of 5-amino-2,4,6-triiodoisophthalamide.
    Haavaldsen J; Nordal V; Kelly M
    Acta Pharm Suec; 1983; 20(3):219-32. PubMed ID: 6637517
    [No Abstract]   [Full Text] [Related]  

  • 7. Physicochemical properties and degree of protein binding of iopentol.
    Skinnemoen K
    Acta Radiol Suppl; 1987; 370():33-6. PubMed ID: 2980308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of non-ionic contrast media on the endothelium of small arteries. A comparison of metrizamide, iohexol and iopentol.
    Wieslander JB; Stjernquist U
    Acta Radiol Suppl; 1987; 370():73-7. PubMed ID: 2980317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, analysis and toxicity of three compounds formed during the synthesis of iodixanol.
    Priebe H; Dugstad H; Heglund IF; Sande R; Tønseth CP
    Acta Chem Scand (Cph); 1995 Oct; 49(10):737-43. PubMed ID: 7577195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of iopentol on acetylcholinesterase activity and thrombin time. Comparative studies.
    Dawson P
    Acta Radiol Suppl; 1987; 370():97-9. PubMed ID: 2980323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of iopentol in healthy volunteers.
    Waaler A; Jørgensen NP; Koksvik B; Skinnemoen K; Andrew E
    Acta Radiol Suppl; 1987; 370():113-7. PubMed ID: 2980304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial program for iopentol. A new nonionic ratio 3.0 contrast medium with emphasis on clinical phases I and II.
    Andrew E; Waaler A; Jakobsen J; Holager T; Lambrechts M; Moxnes A; Kruger Hagen E; Bach-Gansmo T
    Invest Radiol; 1988 Sep; 23 Suppl 1():S189-92. PubMed ID: 3058629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotolerability of nonionic X-ray contrast media. The role of chemotoxicity.
    Luzzani F; Morisetti A; Bussi S; Tirone P; de Haën C
    Invest Radiol; 1996 Jun; 31(6):338-44. PubMed ID: 8761866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report.
    Aakhus T; Stokke O; Stormorken H; Berg KJ; Dahlstrøm K
    Acta Radiol Suppl; 1987; 370():109-12. PubMed ID: 2980303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the risk of ventricular fibrillation by adding sodium to ionic and non-ionic contrast media with low iodine concentration. Coronary perfusion of the isolated rabbit heart with meglumine diatrizoate or iopentol at 140 mg I/ml and 0-154 mmol Na+/l.
    Bååth L; Almén T
    Acta Radiol; 1989; 30(2):207-12. PubMed ID: 2647114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and excretion of iopentol in the pig.
    Leunbach I; Skinnemoen K; Golman K
    Acta Radiol Suppl; 1987; 370():105-7. PubMed ID: 2980302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of iopentol and iohexol after intravenous injection.
    Jakobsen JA; Kolbenstvedt AN; Berg KJ
    Acta Radiol; 1991 Jul; 32(4):320-4. PubMed ID: 1863505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
    Wiklund LM; Brolin I; Sjöholm K
    Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of iopentol on coagulation and platelet function in vitro and in vivo.
    Stormorken H; Testart MC; Braekke G; Sveen K; Jakobsen JA; Grande T; Andrew E
    Acta Radiol Suppl; 1987; 370():93-6. PubMed ID: 2980322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative evaluation of 2 non-ionic contrast media, iopentol (350 mgI/ml) and iopamidol (370 mgI/ml) in coronary angiography].
    Maddestra N; Di Cesare A; Salute L; Toppetti A; Minguzzi P; Marelli C; Bonomo L
    Radiol Med; 1994 Oct; 88(4):396-400. PubMed ID: 7997610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.